Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor

Indian Journal of Pharmaceutical Sciences

Volumn 69, Issue 5, 2007, Pages 712-713

  Bhavna, ^a   Sharma, V ^b   Ali, M ^a   Baboota, S ^a   Ali, J ^a  

^a HAMDARD UNIVERSITY   (India)

^b AMITY UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHITOSAN; CHOLINESTERASE INHIBITOR; NANOPARTICLE;

BRAIN; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; PARTICLE SIZE;

EID: 38349054464     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Kreuter J. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 2001;47:65-81.
2. Barratt GM. Therapeutic applications of colloidal drug carriers. Pharm Sci Tech Today 2000;5:163-71.
3. Gulyaev AE, Gelperina SE, Skidan IN, Antropov AS, Kivman GY, Kreuter J. Significant transport of doxorubicin into the brain with polysorbate 80-coared nanoparticles. Pharm Res 1999;10:15664-9.
4. Schroeder U, Sommerfeld P, Sabel BA. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood brain barrier. Peptides 1998;4:777-80.
5. Soni S, Babbar AK, Sharma RK, Banerjee T, Maitra A. Pharmacoscintigraphic evaluation of polysorbate80-coated shitosan nanoparticles for brain targeting. Am J Drug Deliv 2005;3:205-12.
6. Dorman DC, Brenneman KA, McElveen AM, Lynch SE, Roberts KC, Wong BA. Olfactory transport: A direct route of delivery of inhaled manganese phosphate to the rat brain. J Toxicol Environ Health 2002;65:1493-511.